CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/s41409-020-0807-7.pdf
Reference21 articles.
1. Park JH, Riviere I, Gonen M, Wang X, Senechal B, Curran KJ, et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med. 2018;378:449–59.
2. Hu Y, Sun J, Wu Z, Yu J, Cui Q, Pu C, et al. Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy. J Hematol Oncol. 2016;9:70.
3. Small D. FLT3 mutations: biology and treatment. Hematology. 2006;2006:178–84.
4. Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood 2002;100:1532–42.
5. Jinghui Z, Li D, Linda H, Gang W, Heatley SL, Debbie PT, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157–63.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma;Frontiers in Immunology;2024-04-08
2. Long‐term follow‐up of tandem CD19/CD22 CAR T‐Cells in r/r B‐ALL patients with high‐risk features;American Journal of Hematology;2023-09-04
3. A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells;Frontiers in Immunology;2023-04-27
4. When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies;Frontiers in Oncology;2022-02-23
5. CAR-macrophage: A new immunotherapy candidate against solid tumors;Biomedicine & Pharmacotherapy;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3